Drugs / PHR160
last change Dec 2020 re-read 2 minutes ago

PHR160

Developed for
COVID-19
Investigated by
Baqiyatallah Medical Sciences University

Trials 1 · a red edge is where a trial was stopped

202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT04463420 Aug → Nov 2020 COVID-19 Baqiyatallah Medical Sciences University Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as PHR160 ClinicalTrials.gov intervention name — accepted as the source's own label NCT04463420
Route Oral “one hour oral puff” NCT04463420